Giles-Davis W - Search Results

1

Enhancing CD8⁺ T Cell Fatty Acid Catabolism within a Metabolically Challenging Tumor Microenvironment Increases the Efficacy of Melanoma Immunotherapy.

Zhang Y, Kurupati R, Liu L, Zhou XY, Zhang G, Hudaihed A, Filisio F, Giles-Davis W, Xu X, Karakousis GC, Schuchter LM, Xu W, Amaravadi R, Xiao M, Sadek N, Krepler C, Herlyn M, Freeman GJ, Rabinowitz JD, Ertl HCJ. Zhang Y, et al. Among authors: giles davis w. Cancer Cell. 2017 Sep 11;32(3):377-391.e9. doi: 10.1016/j.ccell.2017.08.004. Cancer Cell. 2017. PMID: 28898698 Free PMC article.

2

The effect of CpG sequences on the B cell response to a viral glycoprotein encoded by a plasmid vector.

Pasquini S, Deng H, Reddy ST, Giles-Davis W, Ertl HC. Pasquini S, et al. Gene Ther. 1999 Aug;6(8):1448-55. doi: 10.1038/sj.gt.3300964. Gene Ther. 1999. PMID: 10467369

3

Viral recombinant vaccines to the E6 and E7 antigens of HPV-16.

He Z, Wlazlo AP, Kowalczyk DW, Cheng J, Xiang ZQ, Giles-Davis W, Ertl HC. He Z, et al. Virology. 2000 Apr 25;270(1):146-61. doi: 10.1006/viro.2000.0271. Virology. 2000. PMID: 10772987 Free article.

4

Staining of antigen activated lymphocytes (SAAL): a highly specific method for flow cytometric quantitation of tumor-specific CD8(+) T cells.

Kowalczyk DW, Wlazlo AP, Giles-Davis W, Ertl HC. Kowalczyk DW, et al. J Immunol Methods. 2000 Jul 31;241(1-2):131-9. doi: 10.1016/s0022-1759(00)00208-8. J Immunol Methods. 2000. PMID: 10915855

5

A method that allows easy characterization of tumor-infiltrating lymphocytes.

Kowalczyk DW, Wlazlo AP, Blaszczyk-Thurin M, Xiang ZQ, Giles-Davis W, Ertl HC. Kowalczyk DW, et al. J Immunol Methods. 2001 Jul 1;253(1-2):163-75. doi: 10.1016/s0022-1759(01)00356-8. J Immunol Methods. 2001. PMID: 11384678

6

Generation and characterization of monoclonal antibodies against the E6 and E7 oncoproteins of HPV.

Wlazlo AP, Giles-Davis W, Clements A, Struble G, Marmorstein R, Ertl HC. Wlazlo AP, et al. Hybridoma. 2001 Aug;20(4):257-63. doi: 10.1089/027245701753179848. Hybridoma. 2001. PMID: 11604112

7

A modified DNA vaccine to p53 induces protective immunity to challenge with a chemically induced sarcoma cell line.

Deng H, Kowalczyk D, O I, Blaszczyk-Thurin M, Quan Xiang Z, Giles-Davis W, Ertl HC. Deng H, et al. Cell Immunol. 2002 Jan;215(1):20-31. doi: 10.1016/s0008-8749(02)00004-7. Cell Immunol. 2002. PMID: 12142033

8

A simian replication-defective adenoviral recombinant vaccine to HIV-1 gag.

Fitzgerald JC, Gao GP, Reyes-Sandoval A, Pavlakis GN, Xiang ZQ, Wlazlo AP, Giles-Davis W, Wilson JM, Ertl HC. Fitzgerald JC, et al. J Immunol. 2003 Feb 1;170(3):1416-22. doi: 10.4049/jimmunol.170.3.1416. J Immunol. 2003. PMID: 12538702

9

Induction of CD8+ T cells to an HIV-1 antigen through a prime boost regimen with heterologous E1-deleted adenoviral vaccine carriers.

Pinto AR, Fitzgerald JC, Giles-Davis W, Gao GP, Wilson JM, Ertl HC. Pinto AR, et al. J Immunol. 2003 Dec 15;171(12):6774-9. doi: 10.4049/jimmunol.171.12.6774. J Immunol. 2003. PMID: 14662882

10

Vaccine-induced CD8+ T cells eliminate tumors by a two-staged attack.

Kowalczyk DW, Wlazlo AP, Giles-Davis W, Kammer AR, Mukhopadhyay S, Ertl HC. Kowalczyk DW, et al. Cancer Gene Ther. 2003 Dec;10(12):870-8. doi: 10.1038/sj.cgt.7700653. Cancer Gene Ther. 2003. PMID: 14712313

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

31 results

Search Page

Filters